🇺🇸 ROIV — Roivant Sciences Ltd.

Salud Compra fuerte
← Volver

Precio actual

36,04 USD

Máx. histórico

41,81

55 días

Caída desde máximo

-13,80%

Rango 52 semanas

19,32 – 42,50

Variación hoy

+0,42%

Cierre anterior

35,89

Rango de hoy

35,56 – 36,78

Volumen hoy

6.686.435

Peor caída histórica

-79,22%

20/12/2021 → 12/05/2022

Recuperado en 1217 días

Volatilidad anualizada ⓘ

55,48%

Información
Nombre completo
Roivant Sciences Ltd.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
721
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
50,00 USD (puede no estar actualizado)
Primera cotización
08/12/2020
Precio actualizado
hace 2 horas
Sobre la empresa

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/08/2026 36,05 36,78 35,68 35,78 -1,54% 3,05% 7.941.200
07/08/2026 35,88 36,44 35,62 36,34 +3,47% 2,29% 6.743.400
06/08/2026 33,11 35,37 33,11 35,12 +1,50% 6,83% 8.248.300
05/08/2026 34,89 35,56 34,35 34,60 +0,03% 3,47% 5.856.700
04/08/2026 33,74 34,70 33,45 34,59 +3,81% 3,70% 5.880.100
03/08/2026 33,23 33,43 32,47 33,32 -1,74% 2,89% 5.986.700
31/07/2026 34,28 34,50 33,54 33,91 -1,77% 2,80% 5.397.100
30/07/2026 33,39 34,54 33,01 34,52 +5,02% 4,58% 4.555.300
29/07/2026 33,85 34,30 32,83 32,87 -2,87% 4,34% 4.824.000
28/07/2026 34,62 34,83 33,50 33,84 -2,53% 3,84% 4.400.100
27/07/2026 35,13 35,58 34,59 34,72 -0,83% 2,82% 4.272.700
24/07/2026 35,23 35,59 34,80 35,01 -0,26% 2,26% 4.043.200
23/07/2026 34,46 35,70 34,14 35,10 +0,54% 4,51% 4.246.700
22/07/2026 34,65 35,13 34,55 34,91 -0,14% 1,67% 3.399.400
21/07/2026 34,14 35,24 34,02 34,96 +2,67% 3,57% 4.726.800
20/07/2026 34,74 35,09 33,96 34,05 -1,33% 3,25% 6.014.300
17/07/2026 33,75 34,84 33,56 34,51 +1,71% 3,78% 3.834.600
16/07/2026 34,54 34,74 33,68 33,93 -2,75% 3,05% 3.990.200
15/07/2026 34,59 35,07 34,34 34,89 -0,06% 2,11% 2.555.800
14/07/2026 34,51 35,13 34,29 34,91 +1,16% 2,43% 4.052.800
13/07/2026 35,34 35,62 34,38 34,51 -4,06% 3,52% 4.774.200
10/07/2026 36,81 37,00 35,27 35,97 -2,28% 4,70% 6.237.600
09/07/2026 36,09 36,91 36,09 36,81 +2,00% 2,26% 5.397.700
08/07/2026 36,15 36,63 35,41 36,09 -0,61% 3,36% 4.267.600
07/07/2026 35,61 36,49 35,07 36,31 +2,60% 3,99% 6.066.000
06/07/2026 35,01 35,72 34,83 35,39 +0,74% 2,54% 5.977.300
02/07/2026 35,35 35,45 34,58 35,13 +0,29% 2,48% 5.079.900
01/07/2026 35,75 35,84 34,58 35,03 -1,02% 3,52% 4.370.600
30/06/2026 34,78 35,90 34,77 35,39 +1,90% 3,26% 6.160.100
29/06/2026 33,85 34,83 33,61 34,73 +1,94% 3,60% 6.384.900